Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002369
Filing Date
2025-01-06
Accepted
2025-01-06 17:53:52
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3985
  Complete submission text file 0000950170-25-002369.txt   5490
Mailing Address TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Somaiya Mayur Ian (Reporting) CIK: 0001760303 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41562 | Film No.: 25512650

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)